S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8+ T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.
Li H, Chen J, Li Z, Chen M, Ou Z, Mo M, Wang R, Tong S, Liu P, Cai Z, Zhang C, Liu Z, Deng D, Liu J, Cheng C, Hu J, Zu X.
Li H, et al. Among authors: hu j.
Adv Sci (Weinh). 2023 Sep;10(25):e2300110. doi: 10.1002/advs.202300110. Epub 2023 Jul 6.
Adv Sci (Weinh). 2023.
PMID: 37414584
Free PMC article.